Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its long-term plans in Ireland.

RTÉ

Ireland

MSD Ireland in deal to buy WuXi Vaccines' Dundalk site

US passed Biosecure Act which would ban federal contracts with targeted firms and their business partners. Legislation explicitly names WuXi.

Ad Fontes Media

All Sides

Media Bias/Fact Check

South China Morning Post

Alibaba Group

Hong Kong

China’s WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom

Government of Ireland

WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company seeks to enhance its margins while continuing to navigate geopolitical tensions.

Business Times

China’s WuXi Biologics to sell vaccine facility to Merck for US$500 million

MSD plans to expand operations at the Dundalk site by adding 150 new roles. Read more: MSD to acquire WuXi Vaccines’ Dundalk site, and plans 1,000 jobs in coming years

Silicon Republic

MSD to acquire WuXi Vaccines' Dundalk site, and plans 1,000 jobs in coming years

Pharmaceutical giant Merck, which operates as MSD outside of the U.S., is to acquire the WuXi Vaccines manufacturing plant in Dundalk as part of a €500M deal, bringing the U.S.-based company’s investment in Ireland to around €3B over the last three years.
The 167K SF Dundalk plant is a three-storey vaccine manufacturing facility, which includes quality control labs and employs about 200 people. MSD and WuXi have collaborated on a vaccine supply …

Bisnow

New Year Boost For Life Sciences As MSD Buys €500M Dundalk Plant

WuXi Biologics partners with Candid Therapeutics, granting global rights to its trispecific T-cell platform. Deal includes $925M in milestones plus royalties, showcasing WuXiBody™ technology.

stocktitan.net

WuXi Biologics Signs $925M Licensing Deal for Novel T-Cell Cancer Therapy Platform

MSD Ireland has agreed to acquire the WuXi Vaccines manufacturing facility in Dundalk, Co Louth for €500m. The deal will increase the size of MSD’s footprint in Ireland to eight locations, and the company plans to add 150 jobs at the 15,520 sq m Dundalk site over the next 12 months.  Around 200 people work on site at present. The site offers drug substance manufacturing, drug product manufacturing, and quality control labs for the supply of vacc…

startupbusinessready.com

150 new jobs as MSD agrees deal for WuXi Vaccines' Dundalk facility #MakeMoneyOnlineFast #OnlineBusiness #DigitalMarketing #EarnMoney #EarnMoneyOnline

WuXi Biologics’ subsidiary WuXi Vaccines is divesting a manufacturing facility in Dundalk, Ireland, to Merck for $500 million, roughly a week after WuXi AppTec also announced it's shrinking its footprint.
WuXi Vaccines expects to close ...

Endpoints News

WuXi Biologics to sell Irish vaccine site to Merck for $500M

MSD Ireland has agreed to acquire the WuXi Vaccines manufacturing facility in Dundalk, Co Louth for €500m. The deal will increase the size of MSD's footprint in Ireland to eight locations, and the company plans to add 150 jobs at the 15,520 sq m Dundalk site over the next 12 months.  Around 200 people work on site at present. The site offers drug substance manufacturing, drug product manufacturing, and quality control labs for the supply of vacc…

Business Plus

150 new jobs as MSD agrees deal for WuXi Vaccines' Dundalk facility

MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk.

MSD Ireland in deal to buy WuXi Vaccines' Dundalk site

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics